ArticleCancer chemotherapy and pharmacology2024

A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure-response relationships: a proof-of-concept study with alectinib.

Lishi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.